e-learning
resources
London 2016
Saturday, 03.09.2016
ERS/French Programme I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Médecine personnalisée et BPCO: où en sommes-nous ?Personalised medicine and COPD: where are we now?
Nicolas Roche (Paris, France)
Source:
International Congress 2016 – ERS/French Programme I
Session:
ERS/French Programme I
Session type:
Session
Number:
113
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicolas Roche (Paris, France). Médecine personnalisée et BPCO: où en sommes-nous ?Personalised medicine and COPD: where are we now?. International Congress 2016 – ERS/French Programme I
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prise en charge de l’emphysème : Approche personnalisée / Management of emphysema: personalised approach
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Asthma in children: an updateAsma nel bambino: un update
Source: International Congress 2017 – ERS Italian Day programme
Year: 2017
COPD: the Italian recommendationBPCO: le raccomandazioni Italiane
Source: International Congress 2017 – ERS Italian Day programme
Year: 2017
Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Thermoplastie bronchique : indications actuelles / Asthma thermoplasty: current indications
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Recommandations européennes ERS/ESC pour le diagnostic et la prise en charge de l’hypertension pulmonaireERS/ESC European guidelines for the diagnosis and treatment of pulmonary hypertension
Source: International Congress 2016 – ERS/French Programme II
Year: 2016
Microbiote et cancer bronchique: l'exemple de l'immunothérapie / Microbiota and lung cancer: an example of immunotherapy
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Où en est-on dans la prise en charge de la Covid en septembre 2021 ? / Management of COVID-19: where are we ?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Spanish registry of bronchiectasis: update and resultsRegistro Español de Bronquiectasias: actualización y resultados
Source: International Congress 2017 – Spanish and Portuguese Programme 2017
Year: 2017
Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care
Source: International Congress 2017 – French Programme 2017
Year: 2017
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Nouvelles perspectives thérapeutiques dans la tuberculose multi-résistanteNew perspectives in the treatment of MDR-TB
Source: International Congress 2016 – ERS/French Programme II
Year: 2016
Le roi est mort, vive le roi?
Source: Eur Respir J, 50 (1) 1701075; 10.1183/13993003.01075-2017
Year: 2017
La thermoplastie dans l’asthme : corrélation clinique et histopathologiqueAsthma thermoplasty: clinical and histopathological correlation
Source: International Congress 2017 – French Programme 2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept